#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14046	16S	1529	1529	99.93	16S.l15.c4.ctg.1	1995	699.2	0	.	n	.	0	C451T	SNP	451	451	C	695	695	T	801	T,C	570,156	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14046	16S	1529	1529	99.93	16S.l15.c4.ctg.1	1995	699.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1428	1428	C	817	C	727	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14046	16S	1529	1529	99.93	16S.l15.c4.ctg.1	1995	699.2	0	HET	.	.	.	C207T,G	.	207	207	C	451	451	C	779	C,T,G	541,151,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25432	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3612	702.4	0	.	n	.	0	T695C	SNP	695	695	T	1070	1070	C	738	C	649	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25432	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3612	702.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2346	2346	C	826	C	737	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25432	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3612	702.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2420	2420	A	813	A	736	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25432	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3612	702.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2972	2972	C	771	C,A,T	690,3,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25432	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3612	702.4	0	HET	.	.	.	A1638G	.	1638	1638	A	2013	2013	A	817	A,G	449,299	.	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1806	folP	855	855	100.0	folP.l15.c4.ctg.1	1324	135.6	1	SNP	p	R229S	1	.	.	685	687	AGC	947	949	AGC	170;175;177	A;G;C	148;152;153	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3617	136.9	1	SNP	p	S91F	1	.	.	271	273	TTC	704	706	TTC	155;154;155	T;T;C	143;144;144	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3617	136.9	1	SNP	p	G95N	0	.	.	283	285	GGC	716	718	GGC	166;165;168	G;G;C,A	151;149;152,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4956	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3617	136.9	1	SNP	p	D95G	1	.	.	283	285	GGC	716	718	GGC	166;165;168	G;G;C,A	151;149;152,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	1412	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1149	122.2	1	SNP	p	G45D	0	.	.	133	135	GGC	391	393	GGC	194;194;196	G;G;C	171;169;173	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	654	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	1131	57.8	0	.	n	.	0	A197.	DEL	197	197	A	526	526	A	171	A	161	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2882	198.6	1	SNP	p	D86N	0	.	.	256	258	GAC	580	582	GAC	225;225;226	G;A;C	200;191;200	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2882	198.6	1	SNP	p	R87I	0	.	.	259	261	CGT	583	585	CGT	228;229;228	C;G;T	205;199;197	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2882	198.6	1	SNP	p	S87R	1	.	.	259	261	CGT	583	585	CGT	228;229;228	C;G;T	205;199;197	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2882	198.6	1	SNP	p	R87W	0	.	.	259	261	CGT	583	585	CGT	228;229;228	C;G;T	205;199;197	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5748	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2882	198.6	1	SNP	p	S88P	0	.	.	262	264	TCC	586	588	TCC	229;225;226	T;C;C	202;198;201	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4010	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2636	151.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1547	1549	GGC	209;205;200	G;G;C	196;189;187	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1307	1309	GCC	186;189;190	G;C;C	175;179;178	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1310	1312	ATG	188;189;190	A;T;G	178;176;177	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1322	1324	ACC	188;189;191	A;C;C	172;176;175	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1322	1324	ACC	188;189;191	A;C;C	172;176;175	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1823	1825	ACC	227;226;227	A;C;C	199;200;203	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1877	1879	GCG	220;221;222	G;C;G	203;201;203	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1877	1879	GCG	220;221;222	G;C;G	203;201;203	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2000	2002	GGT	155;154;155	G;G;T	143;143;139	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2009	2011	AGC	154;155;154	A;G;C	141;143;141	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3642	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2417	150.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2027	2029	CCG	141;144;144	C,CGG;C,G;G	98,1;102,2;103	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5632	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	2868	195.3	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1504	1506	CCG	179;181;182	C;C,T;G	156;162,1;162	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2306	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1728	132.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	491	491	C	186	C	172	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1369	205.2	1	SNP	p	G120K	1	.	.	358	360	AAG	545	547	AAG	223;225;227	A;A;GAA,GAAA	205;211;206,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1369	205.2	1	SNP	p	N121D	0	.	.	361	363	AAC	548	550	AAC	225;224;222	A;A;C	209;209;204	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	2854	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1369	205.2	1	SNP	p	A121N	1	.	.	361	363	AAC	548	550	AAC	225;224;222	A;A;C	209;209;204	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10620	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4741	223.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1064	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	965	109.9	1	SNP	p	V57M	1	.	.	169	171	ATG	455	457	ATG	244;244;241	A;T;G	216;215;212	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
